Fragment-based discovery of AT9283; a multi-targeted kinase inhibitor with potent Aurora kinase activity

被引：0
作者：
Howard, S. [1 ]
Berdini, V. [2 ]
Curry, J. [3 ]
Gill, A. L. [1 ]
Richardson, C. J. [3 ]
Rees, D. [1 ]
Reule, M. [3 ]
Tisi, D. [4 ]
Wyatt, P. [1 ]
Fazal, L. [3 ]
机构：
[1] Astex Therapeut, Med Chem, Cambridge, England
[2] Astex Therapeut, Computat Chem, Cambridge, England
[3] Astex Therapeut, Biol, Cambridge, England
[4] Astex Therapeut, Struct Biol, Cambridge, England
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72221-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [31] The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
    Michaelis, Martin
    Paulus, Christina
    Loeschmann, Nadine
    Dauth, Stephanie
    Stange, Elisabeth
    Doerr, Hans Wilhelm
    Nevels, Michael
    Cinatl, Jindrich, Jr.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (06) : 1079 - 1090
  • [32] A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
    Brian D. Ross
    Youngsoon Jang
    Amanda Welton
    Christopher A. Bonham
    Dilrukshika S. W. Palagama
    Kevin Heist
    Jagadish Boppisetti
    Kasun P. Imaduwage
    Tanner Robison
    Leah R. King
    Edward Z. Zhang
    Cyrus Amirfazli
    Kathryn E. Luker
    Winston Y. Lee
    Gary D. Luker
    Thomas L. Chenevert
    Marcian E. Van Dort
    Nature Communications, 13
  • [33] A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
    Ross, Brian D.
    Jang, Youngsoon
    Welton, Amanda
    Bonham, Christopher A.
    Palagama, Dilrukshika S. W.
    Heist, Kevin
    Boppisetti, Jagadish
    Imaduwage, Kasun P.
    Robison, Tanner
    King, Leah R.
    Zhang, Edward Z.
    Amirfazli, Cyrus
    Luker, Kathryn E.
    Lee, Winston Y.
    Luker, Gary D.
    Chenevert, Thomas L.
    Van Dort, Marcian E.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [34] The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
    Martin Michaelis
    Christina Paulus
    Nadine Löschmann
    Stephanie Dauth
    Elisabeth Stange
    Hans Wilhelm Doerr
    Michael Nevels
    Jindrich Cinatl
    Cellular and Molecular Life Sciences, 2011, 68 : 1079 - 1090
  • [35] Thienopyrimidine ureas as novel, potent multi-targeted receptor tyrosine kinase inhibitors
    Dai, YJ
    Guo, Y
    Frey, RR
    Ji, ZQ
    Curtin, ML
    Ahmed, AA
    Albert, DH
    Arnold, L
    Arries, SS
    Barlozzari, T
    Bauch, JL
    Bouska, JJ
    Bousquet, PF
    Cunha, GA
    Glaser, KB
    Guo, J
    Li, JL
    Marcotte, PM
    Marsh, KC
    Moskey, MD
    Pease, LJ
    Stewart, KD
    Stoll, VS
    Tapang, P
    Wishart, N
    Davidsen, SK
    Michaelides, MR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2765 - U2765
  • [36] Substrate activity screening: A fragment-based method for inhibitor discovery
    Ellman, Jonathan A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [37] A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191
    Hay, Annette E.
    Murugesan, Alli
    DiPasquale, Ashley M.
    Kouroukis, Tom
    Sandhu, Irwindeep
    Kukreti, Vishal
    Bahlis, Nizar J.
    Lategan, Johan
    Reece, Donna E.
    Lyons, John F.
    Sederias, Joana
    Xu, Hao
    Powers, Jean
    Seymour, Lesley K.
    Reiman, Tony
    LEUKEMIA & LYMPHOMA, 2016, 57 (06) : 1463 - 1466
  • [38] Dasatinib (BMS-354825): A multi-targeted kinase inhibitor with activity against multiple myeloma.
    Deng, QW
    Mitsiades, N
    Negri, J
    Wen, ZQ
    Rooney, M
    Hideshima, T
    Chauhan, D
    Munshi, NC
    Richardson, PG
    Lee, FY
    Anderson, KC
    Mitsiades, CS
    BLOOD, 2005, 106 (11) : 451A - 451A
  • [39] A multi-targeted tyrosine kinase inhibitor lenvatinib for the treatment of mice with advanced glioblastoma
    Li, Jia
    Zou, Chang-Lin
    Zhang, Zhi-Ming
    Lv, Lian-Jie
    Qiao, Hai-Bo
    Chen, Xiu-Ju
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 7105 - 7111
  • [40] Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase
    Adams, Nicholas D.
    Adams, Jerry L.
    Burgess, Joelle L.
    Chaudhari, Amita M.
    Copeland, Robert A.
    Donatelli, Carla A.
    Drewry, David H.
    Fisher, Kelly E.
    Hamajima, Toshihiro
    Hardwicke, Mary Ann
    Huffman, William F.
    Koretke-Brown, Kristin K.
    Lai, Zhihong V.
    McDonald, Octerloney B.
    Nakamura, Hiroko
    Newlander, Ken A.
    Oleykowski, Catherine A.
    Parrish, Cynthia A.
    Patrick, Denis R.
    Plant, Ramona
    Sarpong, Martha A.
    Sasaki, Kosuke
    Schmidt, Stanley J.
    Silva, Domingos J.
    Sutton, David
    Tang, Jun
    Thompson, Christine S.
    Tummino, Peter J.
    Wang, Jamin C.
    Xiang, Hong
    Yang, Jingsong
    Dhanak, Dashyant
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) : 3973 - 4001
12345